Clinical Trials Directory

Trials / Sponsors / Biotest Pharmaceuticals Corporation

Biotest Pharmaceuticals Corporation

Industry · 6 registered clinical trials.

StatusTrialPhaseStarted
CompletedCivacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Pa
Hepatitis C Infection, Viruses, Hepatocellular Carcinoma
Phase 32013-06-01
CompletedBT062 in Combination With Lenalidomide or Pomalidomide and Dexamethasone in Patients With Multiple Myeloma
Multiple Myeloma
Phase 1 / Phase 22012-07-03
CompletedSafety and Dose Determining Multi-dose Study of BT062 in Patients With Relapsed or Refractory Multiple Myeloma
Multiple Myeloma
Phase 1 / Phase 22010-08-01
WithdrawnNabi-HB Administered Subcutaneously in Patients With Hepatitis B Virus Post Liver Transplantation
Hepatitis B, Chronic
Phase 32010-04-01
CompletedSafety and Dose Determining Study of BT062 in Patients With Relapsed or Refractory Multiple Myeloma
Multiple Myeloma
Phase 12008-08-01
CompletedPilot Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin (Boca HBVIg) Use
Hepatitis B Virus Associated Liver Disease
Phase 1 / Phase 21999-11-01